Alcon Inc. (ALC - Free Report) delivered core earnings per share (EPS) of 56 cents for the second quarter of 2021 as against loss per share of 21 cents a year ago. The figure exceeded the Zacks Consensus Estimate by 30.3%. Alcon’s “core” results are non-IFRS (International Financial Reporting Standards) measures.
Second-quarter reported EPS of 31 cents came in contrast to loss per share of 86 cents in the year-earlier quarter.
Revenues in Detail
Revenues in the second quarter totaled $2.09 billion, beating the Zacks Consensus Estimate by 6.7%. The top line improved 74.8% from the year-ago number (up 69% at constant exchange rate or CER). Each of the company’s reporting segments benefited from the improvements in the eye care market, led by strong recovery in the United States and varied paces of recovery in international markets from the COVID-19 pandemic.
In the second quarter, Total Surgical (consisting of Implantables, Consumables and Equipment/other) reported sales of $1.21 billion, up 100% on a reported basis (up 94% at CER).
Highest Returns for Any Asset Class
It’s not even close. Despite ups and downs, Bitcoin has been more profitable for investors than any other decentralized, borderless form of money.
No guarantees for the future, but in the past three presidential election years, Bitcoin’s returns were as follows: 2012 +272.4%, 2016 +161.1%, and 2020 +302.8%. Zacks predicts another significant surge in months to come.
Hurry, Download Special Report – It’s FREE >>
Alcon Inc. (ALC - Free Report) delivered core earnings per share (EPS) of 56 cents for the second quarter of 2021 as against loss per share of 21 cents a year ago. The figure exceeded the Zacks Consensus Estimate by 30.3%. Alcon’s “core” results are non-IFRS (International Financial Reporting Standards) measures.
Second-quarter reported EPS of 31 cents came in contrast to loss per share of 86 cents in the year-earlier quarter.
Revenues in Detail
Revenues in the second quarter totaled $2.09 billion, beating the Zacks Consensus Estimate by 6.7%. The top line improved 74.8% from the year-ago number (up 69% at constant exchange rate or CER). Each of the company’s reporting segments benefited from the improvements in the eye care market, led by strong recovery in the United States and varied paces of recovery in international markets from the COVID-19 pandemic.
In the second quarter, Total Surgical (consisting of Implantables, Consumables and Equipment/other) reported sales of $1.21 billion, up 100% on a reported basis (up 94% at CER).
Highest Returns for Any Asset Class
It’s not even close. Despite ups and downs, Bitcoin has been more profitable for investors than any other decentralized, borderless form of money.
No guarantees for the future, but in the past three presidential election years, Bitcoin’s returns were as follows: 2012 +272.4%, 2016 +161.1%, and 2020 +302.8%. Zacks predicts another significant surge in months to come.
Hurry, Download Special Report – It’s FREE >>
Get the latest research report on ALC - FREE
Get the latest research report on BIO - FREE
Get the latest research report on WST - FREE
Get the latest research report on EHC - FREE